Gilead Raday

CIK: 0002113137

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)3 (50.0%)

Position reduction

Option Exercises (M)3 (50.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

RDHL

RedHill Biopharma Ltd.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

RDHL
RedHill Biopharma Ltd.
Oct 1, 2026
Sale(S)
Direct
14.3M shares at avg. $0.00$1K
RDHL
RedHill Biopharma Ltd.
Oct 1, 2026
Exercise(M)
American Depository Shares
Direct
27.6M shares-
RDHL
RedHill Biopharma Ltd.
Jul 10, 2026
Sale(S)
Direct
14.1M shares at avg. $0.00$1K
RDHL
RedHill Biopharma Ltd.
Jul 10, 2026
Exercise(M)
American Depositary Shares
Direct
28.2M shares-
RDHL
RedHill Biopharma Ltd.
Apr 6, 2026
Sale(S)
Direct
15.7M shares at avg. $0.00$2K
RDHL
RedHill Biopharma Ltd.
Apr 6, 2026
Exercise(M)
American Depositary Shares
Direct
30.8M shares-

		Type	Shares	Price		Ownership
Oct 1, 2026	RDHL RedHill Biopharma Ltd.	Sale(S)	14,310,000	$0.00	$1,431	Direct
Oct 1, 2026	RDHL RedHill Biopharma Ltd.	Exercise(M) American Depository Shares	27,560,000	-	-	Direct
Jul 10, 2026	RDHL RedHill Biopharma Ltd.	Sale(S)	14,130,000	$0.00	$1,413	Direct
Jul 10, 2026	RDHL RedHill Biopharma Ltd.	Exercise(M) American Depositary Shares	28,150,000	-	-	Direct
Apr 6, 2026	RDHL RedHill Biopharma Ltd.	Sale(S)	15,740,000	$0.00	$1,574	Direct
Apr 6, 2026	RDHL RedHill Biopharma Ltd.	Exercise(M) American Depositary Shares	30,780,000	-	-	Direct

1-6 of 6 transactions

About Raday Gilead

Raday Gilead (SEC CIK 0002113137) files insider reports with the SEC as Chief Operating Officer of RedHill Biopharma Ltd. (RDHL).

Signal8 holds 4 ownership filings by Raday Gilead (1 Form 3, 3 Form 4), filed between Mar 18, 2026 and Oct 6, 2026. Those filings report 6 transactions, from Apr 6, 2026 to Oct 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Raday Gilead's filings is in TEL AVIV.

Recent filings by Raday Gilead

Oct 1, 2026: Open-market sale of RDHL shares (Form 4, code S).
Oct 1, 2026: Option exercise of RDHL derivative securities (Form 4, code M).
Jul 10, 2026: Open-market sale of RDHL shares (Form 4, code S).
Jul 10, 2026: Option exercise of RDHL derivative securities (Form 4, code M).
Apr 6, 2026: Open-market sale of RDHL shares (Form 4, code S).

Other insiders filing for RedHill Biopharma Ltd. (RDHL)

Tsimchi Ofer, Director
Scruggs Rick D, Chief Commercial Officer
Reed Kenneth, Director
Mamluk Roni, Director
Ingber Razi, Chief Financial Officer
Goldberg Guy Joel, Chief Business Officer

How to read Form 4 transaction codes